Shares
Market wrap: what we learnt from reporting season
As the final week of corporate reporting season comes to an end, investors can now breathe a sigh of relief, but what can we expect from the market now?
Drop in new car sales hits Aussie fleet management group
High debt is forcing more Aussies to buy cheaper cars or refinance existing vehicles, so what does that mean for salary packaging and fleet management company Smartgroup?
Universal Health Services: a stock in the pink of health
When Universal Health Services reported better than expected earnings and revenue for the second quarter of 2019, the company's share price reached a record high of US$152.87 a few days later.
Will Healius be the next healthcare company to outperform?
In a market where it's tough to find value, healthcare business Healius (ASX:HLS) could be the next company to outperform.
The sorry tale of the ASX top 10 highlights an important lesson
The blue chips in the ASX top 10 have proved to be resilient, even despite this week's sell-off. But apart from CSL, their share prices have barely budged.
The highs and lows of thrill-seeking stock Experience Co
The stock market has been a rollercoaster ride over the last few weeks, but Experience Co shareholders have been on an adventure-filled ride for years.
Market wrap: what to expect from August reporting season
The much-anticipated reporting season is critical to understanding the direction of the market over the next 12 months, and could not have come at a more interesting time with the Australian market recently making a new all-time high.
The Australian share sectors that pay the best dividends
Watch out if you want income from health care or technology shares. The Australian sharemarket is one of the highest dividend payers in the world but not all sectors are equal where dividends are concerned.
New CEO will struggle to lift NAB profits for shareholders
Ross McEwan will take over as NAB CEO no later than April 2020, but it's difficult to see how he can change the bank's profitability problems.
Boston Scientific is at the forefront of a $US147b industry
The US remains the world's largest medical device market with no signs of slowing, and Boston Scientific is at the forefront of the ultra-competitive industry.
